Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1238-1242

  Banerjee, Tanushree ^a   Sharma, Shailendra Kumar ^b   Surolia, Namita ^c   Surolia, Avadhesha ^a,b  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

EGCG; Enoyl ACP reductase; Malaria; PfENR; Plasmodium falciparum; Slow; Tight binding inhibitor; Triclosan

Indexed keywords

ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); EPIGALLOCATECHIN GALLATE; TRICLOSAN;

ARTICLE; COMPLEX FORMATION; DISSOCIATION CONSTANT; DRUG MECHANISM; ENZYME INHIBITION; ISOMERIZATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; CATECHIN; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); ENZYME INHIBITORS; PLASMODIUM FALCIPARUM; TRICLOSAN;

PLASMODIUM FALCIPARUM;

EID: 56349158676     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.135     Document Type: Article

References (26)

1. WHO. Communicable Disease Repot - Roll Back Malaria [online] , (2002) 1-19.
2. Surolia N., and Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 7 (2001) 167-173
3. Rock C.O., and Cronan J.E. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim. Biophys. Acta 1302 (1996) 1-16
4. Smith S., Witkowski A., and Joshi A.K. Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42 (2003) 289-317
5. Surolia A., Ramya T.N.C., Ramya V., and Surolia N. 'FAS't inhibition of malaria. Biochem. J. 383 (2004) 401-412
6. Waller R.F., Ralph S.A., Reed M.B., Su V., Douglas J.D., Minnikin D.E., Cowman A.F., Besra G.S., and McFadden G.I. A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum. Antimicrob. Agents Chemother. 47 (2003) 297-301
7. Kapoor M., Dar M.J., Surolia A., and Surolia N. Kinetic determination of the interaction of Enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem. Biophys. Res. Commun. 289 (2001) 832-837
8. Kapoor M., Reddy C.C., Krishnasastry M.V., Surolia N., and Surolia A. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem. J. 381 (2004) 719-724
9. +. Biochem. J. 381 (2004) 725-733
10. Kapoor M., Gopalakrishnapai J., Surolia N., and Surolia A. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl carrier protein) reductase from Plasmodium falciparum. Biochem. J. 381 (2004) 735-741
11. Pidugu L.S., Kapoor M., Surolia N., Surolia A., and Suguna K. Structural basis for the variation in triclosan affinity to Enoyl Reductases. J. Mol. Biol. 343 (2004) 147-155
12. Chhibber M., Kumar G., Parasuraman P., Ramya T.N., Surolia N., and Surolia A. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Bioorg. Med. Chem. 14 (2006) 8086-8098
13. Mishra S., Karmodiya K., Parasuraman P., Surolia A., and Surolia N. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents. Bioorg. Med. Chem. 16 (2008) 5536-5546
14. Kumar G., Parasuraman P., Sharma S.K., Banerjee T., Karmodiya K., Surolia N., and Surolia A. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. J. Med. Chem. 50 (2007) 2665-2667
15. Sharma S.K., Parasuraman P., Kumar G., Surolia N., and Surolia A. Green tea catechins potentiates triclosan binding to Enoyl ACP Reductase from Plasmodium falciparum PfENR. J. Med. Chem. 50 (2007) 765-775
16. Taylor N. Green Tea: The Natural Secret for a Healthier Life (1998), Kensington Publishing Corp., New York
17. Cooper R., Morré D.J., and Morré D.M. Medicinal benefits of green tea: part II. Review of anticancer properties. J. Alternat. Complement. Med. 11 (2005) 639-652
18. Yang C.S., and Wang Z.Y. Tea and cancer. J. Natl. Cancer Inst. 85 (1993) 1038-1049
19. Bastianetto S., Yao Z.X., Papadopoulos V., and Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur. J. Neurosci. 23 (2006) 55-64
20. Dorchies O.M., Wagner S., Vuadens O., Waldhauser K., Buetler T.M., Kucera P., and Ruegg U.T. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am. J. Physiol. Cell. Physiol. 290 (2006) 616-625
21. Zhang Y.M., and Rock C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279 (2004) 30994-31001
22. Tasdemir D., Lack G., Burn R., Ruedi P., Scapozza L., and Perozzo R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J. Med. Chem. 49 (2006) 3345-3353
23. Sharma S.K., Kumar G., Kapoor M., and Surolia A. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun. 368 (2008) 12-17
24. Zhang Y.M., Lu Y.J., and Rock C.O. The reductase steps of the type II fatty acid synthase as antimicrobial targets. Lipids 39 (2004) 1055-1060
25. Morrison J.F., and Walsh C. The behaviour and significance of slow tight binding enzyme inhibitors. Adv.Enzymol. Relat. Areas Mol. Biol. 61 (1988) 201-301
26. Morrison J.F. The slow binding and slow, tight-binding inhibition of enzyme catalysed reactions. Trends Biochem. Sci. 7 (1982) 102-105